Sunshine Lake Pharma Co., Ltd. (HKG:6887)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
40.50
+0.02 (0.05%)
Oct 22, 2026, 4:08 PM HKT

Sunshine Lake Pharma Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
3,9534,8154,0196,2953,745913.79
Revenue Growth
-17.91%19.81%-36.15%68.08%309.83%-61.08%
Gross Profit
2,7963,6853,0594,9862,846483.7
Operating Income
72.49691.16358.812,790322.72-458.11
Net Income
-284.91272.44-207.431,99376.6-587.65
Earnings Per Share
-0.520.55-0.478.570.33-2.54
EPS Growth
---2496.14%--

Revenue by Geography

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Peoples Republic of China (PRC)
3,8574,7253,8806,2953,745913.79
Overseas
95.2390.28138.43---
Total
3,9534,8154,0196,2953,745913.79

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
1,4891,5031,4851,6741,2141,131
Total Debt
5,3134,6804,6242,6093,8223,194
Net Cash (Debt)
-3,824-3,177-3,140-934.92-2,608-2,062
Net Cash Growth
------
Net Cash Per Share
-7.03-6.38-7.12-4.03-11.24-8.89

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
241.631,155500.531,6731,700-662.51
Capital Expenditures
-138.36-836.04-1,062-343.72-570.07-356.29
Free Cash Flow
103.27319.14-561.371,3291,130-1,019
Free Cash Flow Growth
-67.64%--17.67%--

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
70.73%76.54%76.11%79.21%76.00%52.93%
Operating Margin
1.83%14.35%8.93%44.33%8.62%-50.13%
Pretax Margin
-5.69%9.13%3.51%33.79%1.05%-73.01%
Profit Margin
-7.21%5.66%-5.16%31.66%2.05%-64.31%
FCF Margin
2.61%6.63%-13.97%21.12%30.17%-111.49%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
5.690-----
Dividend Per Share Growth
0%-----
Dividend Yield
14.05%-----

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
-86.66-3.8066.05-
P/FCF Ratio
195.3673.98-5.704.48-
PS Ratio
5.104.901.971.201.354.79